Positron emission tomography in the management of unknown primary head and neck carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 7, 2005, Pages 626-629

  Miller, Frank R ^a   Hussey, David ^b   Beeram, Mural ^a   Eng, Tony ^b   McGuff, H Stan ^b   Otto, Randal A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CERVICAL LYMPH NODE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOSCOPY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; LARYNGOSCOPY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; POSITRON EMISSION TOMOGRAPHY; SQUAMOUS CELL CARCINOMA; TONSILLECTOMY; UNIVERSITY HOSPITAL;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TONGUE NEOPLASMS; TONSILLAR NEOPLASMS;

EID: 23044476943     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.131.7.626     Document Type: Article

References (19)

1. van Veen SA, Balm AJ, Valdes-Olmos RA, et al. Occult primary tumors of the head and neck: accuracy of thallium 201 single-photon emission computed tomography and computed tomography and/or magnetic resonance imaging. Arch Otolaryngol Head Neck Surg. 2001;127:406-411.
2. Nguyen C, Shenouda G, Black MJ, Vuong T, Donath D, Yassa M. Metastatic squamous cell carcinoma to cervical lymph nodes from unknown primary mucosal sites. Head Neck. 1994;16:58-63.
3. Maulard C, Housett M, Brunel P, et al. Postoperative radiation therapy for cervical lymph node metastases from an occult squamous cell carcinoma. Laryngoscope. 1992;102:884-890.
4. Harper CS, Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR. Cancer in neck nodes with unknown primary site: role of mucosal radiotherapy. Head Neck. 1990;12:463-469.
5. 18F]-fluoro-2- deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unkown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg. 2000;123:294-301.
6. Koch WM, Bhatti N, Wiliams MF, Eisele DW. Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg. 2001;124:331-333.
7. Mendenhall WM, Mancuso AA, Parsons JT, Stringer SP, Cassisi NJ. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck. 1998;20:739-744.
8. Keyes JW Jr, Watson NE Jr, Williams DW III, Greven KM, McGuirt WF. FDG PET in head and neck cancer. AJR Am J Roentgenol. 1997;169:1663-1669.
9. Braams JW, Pruim J, Kole AC, et al. Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofac Surg. 1997;26:112-115.
10. 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med. 2001;28:816-821.
11. Bohuslavizki KH, Klutmann S, Kroger S, et al. FDG PET detection of unknown primary tumors. J Nucl Med. 2000;41:816-822.
12. Fogarty GB, Peters LJ, Stewart J, Scott C, Rischin D, Hicks RJ. The usefulness of fluorine 18 labelled-deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor. Head Neck. 2003;25:138-145.
13. Johansen J, Eigtved A, Buchwald C, Theilgaard SA, Hansen HS. Implications of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck. Laryngoscope. 2002;112:2009-2014.
14. McQuone SJ, Eisele DW, Lee DJ, Westra WH, Koch WM. Occult tonsillar carcinoma in the unknown primary. Laryngoscope. 1998;108:1605-1610.
15. Wax MK, Myers LL, Gabalski EC, Husain S, Gona JM, Nabi H. Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer. Arch Otolaryngol Head Neck Surg. 2002;128:703-707.
16. Greene FL, Balch CM, Fleming A, Fritz DG, Haller M, Morrow DL. AJCC Cancer Staging Manual. 6th ed. New York: Springer Verlag NY Inc; 2002.
17. Wax MK, Myers LL, Gona JM, Husain SS, Nabi HA. The role of PET in the evaluation of the N-positive neck. Otolaryngol Head Neck Surg. 2003;129:163-167.
18. Schoder H, Yeung HWD, Gonen M, Kraus D, Larson SM. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004;231:65-72.
19. Goerres GW, von Schulthes GK, Steinert HC. Why most PET of lung and head-and-neck cancer will be PET/CT. J Nucl Med. 2004;45(suppl 1):66S-71S.